In addition, CDK11 has also been proved to be a positive modulator of the Wnt/β-catenin signaling cascade, whose dysregulation contributes to the development of cancer, using a kinase-targeted high-throughput siRNA screen [84]. The gene discussed is CDK19; the disease is cancer.